Comparison of the HOTV and Lea Symbols Visual Acuity Tests in Patients With Amblyopia

Ruttum, Mark S.; Dahlgren, Matthew
May 2006
Journal of Pediatric Ophthalmology & Strabismus;May/Jun2006, Vol. 43 Issue 3, p157
Academic Journal
Purpose: To determine whether the Lea symbols visual acuity test, compared with the HOTV visual acuity test, overestimates visual acuity in patients with amblyopia. Patients and Methods: Fifty-nine patients with amblyopia or a history of amblyopia treatment had visual acuity measurements in both eyes with the HOTV and Lea symbols tests. Crowding bars, separated by a width of 1 optotype, and the original pilot-testing protocol in the Amblyopia Treatment Study were used to quantify visual acuity. Results: The patients' ages ranged from 4 to 35 years (mean age, 10.1 years). Visual acuity in the amblyopic eyes ranged from 20/20 to 20/250. The mean visual acuity difference (HOTV scores vs Lea symbols scores) was -0.056 logMAR units (P < .001), slightly more than half of a line. The negative value indicates that patients performed better on the HOTV test. In nonamblyopic eyes, the mean difference was -0.05 logMAR units (P < .001). Patients with strabismic amblyopia had a mean difference of -0.05 logMAR units (P = .08); those with anisometropic amblyopia had a mean difference of -0.07 logMAR units (P = .002). Patients 8 years and younger had a mean difference of -0.04 logMAR units (P = .05); those older than 8 years had a mean difference of -0.06 logMAR units (P = .002). Conclusions: In both amblyopic and nonamblyopic eyes, visual acuity measurements were better on HOTV testing compared with Lea symbols testing. The differences persisted regardless of patient age and the cause and severity of amblyopia. Overestimation of visual acuity by the Lea symbols test was not found.


Related Articles

  • A Patient With Bilateral Persistent Pupillary Membrane: A Conservative Approach. Kurt, Emin // Journal of Pediatric Ophthalmology & Strabismus;Sep/Oct2009, Vol. 46 Issue 5, p300 

    The author describes the case of a girl with bilateral persistent pupillary membranes and good visual acuity. An otherwise healthy 10-year-old girl presented with persistent pupillary membranes in both eyes since childhood. The patient had ametropic amblyopia, which was treated with spectacles...

  • Anisometropic Amblyopia and Nasolacrimal Duct Obstruction. Simon, John W.; Ngo, Yen; Ahn, Eric; Khachikian, Steven // Journal of Pediatric Ophthalmology & Strabismus;May/Jun2009, Vol. 46 Issue 3, p182 

    The authors describe five children with nasolacrimal duct obstruction who developed anisometropic amblyopia in the same eye. Because three children had no indication of vision loss at their initial presentation, cycloplegic refraction and periodic visual acuity screenings for such patients is...

  • Phakic iris-claw lenses feasible alternative in amblyopic children. Cimberle, Michela // Ocular Surgery News;7/10/2009, Vol. 27 Issue 13, p14 

    The article reports that ophthalmologist Camille Budo has announced at the "Ocular Surgery News" Symposium held in Rome, Italy from May 22-23, 2009 that pediatric amblyopic patients implanted with phakic iris-claw lenses had a marked improvement in refraction and good visual acuity results. He...

  • Effect of oral CDP-choline on visual function in young amblyopic patients. Michela Fresina; Anna Dickmann; Annabella Salerni; Fabio De Gregorio; Emilio Campos // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2008, Vol. 246 Issue 1, p143 

    Abstract Purpose  The purpose of the study was to evaluate the effect on visual function of orally administered CDP-choline in addition to patching for the treatment of amblyopia in children. Methods  This was an open label parallel group study comparing...

  • Predicting potential acuities in amblyopes. William Ridder; Michael Rouse // Documenta Ophthalmologica;May2007, Vol. 114 Issue 3, p135 

    Abstract Purpose  Amblyopic patients, or their parents, often want to know the potential for success before committing to treatment. Recent reports have indicated that the pattern visual evoked potential (pVEP) can be used as a predictor of the success of amblyopia therapy....

  • Efficiency of occlusion therapy for management of amblyopia in older children. Brar, Gagandeep S.; Bandyopadhyay, Supratik; Kaushik, Sushmita; Raj, Surishti // Indian Journal of Ophthalmology;Dec2006, Vol. 54 Issue 4, p257 

    Purpose: To analyse results of full time occlusion therapy for amblyopia in children older than 6 years.Materials and Methods: This was a retrospective consecutive case series analysis of children treated for amblyopia at a tertiary care center. All children received...

  • Impact of amblyopia on vision at age 12 years: findings from a population-based study. Robaei, D.; Kifley, A.; Rose, K. A.; Mitchell, P. // Eye;Apr2008, Vol. 22 Issue 4, p496 

    AimsTo report prevalence of amblyopia and long-term impact of its treatment on vision in a population-based sample of 12-year-old Australian children.MethodsLogarithm of minimum angle of resolution (logMAR) visual acuity (VA) was measured in 2353 children (response rate 75.3%); visual impairment...

  • Current Concepts of Amblyopia: A Neuro-Ophthalmology Perspective. Roper-Hall, Gill // American Orthoptic Journal;2007, Vol. 57, p2 

    Amblyopia can be defined as a developmental disorder in which there is a deficit in visual acuity that cannot be improved by refractive correction and that has no detectable organic cause. It has been recognized as a clinical entity for over 300 years. Amblyopia can no longer be considered a...

  • Contrast gain control and cortical TrkB signaling shape visual acuity. Heimel, J. Alexander; Saiepour, M. Hadi; Chakravarthy, Sridhara; Hermans, Josephine M.; Levelt, Christiaan N. // Nature Neuroscience;May2010, Vol. 13 Issue 5, p642 

    During development and aging and in amblyopia, visual acuity is far below the limitations set by the retina. Expression of brain-derived neurotrophic factor (BDNF) in the visual cortex is reduced in these situations. We asked whether neurotrophic tyrosine kinase receptor, type 2 (TrkB) regulates...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics